Characterization of Infections After Chimeric Antigen Receptor T-Cell Therapy in Patients With Large B-Cell Lymphoma

被引：0
|
作者：
Pernas, Berta [1 ]
Iacoboni, Gloria [2 ]
Los-Arcos, Ibai [2 ]
Catala, Eva [2 ]
Carpio, Cecilia [2 ]
Barba, Pere [2 ]
Ruiz-Camps, Isabel [2 ]
机构：
[1] Univ Hosp A Coruna, La Coruna, Spain
[2] Vall dHebron Hosp, Barcelona, Spain
来源：
BONE MARROW TRANSPLANTATION | 2021年 / 56卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P015
引用
收藏
页码：196 / 196
页数：1
相关论文
共 50 条
  • [31] Metabolic Tumor Volume Response after Bridging Therapy Determines Chimeric Antigen Receptor T-Cell Outcomes in Large B-Cell Lymphoma
    Hubbeling, Harper
    Leithner, Doris
    Silverman, Emily A.
    Flynn, Jessica
    Devlin, Sean
    Shah, Gunjan
    Fregonese, Beatrice
    Wills, Beatriz
    Bedmutha, Akshay
    Tomas, Ana Alarcon
    Parascondola, Allison
    Saldia, Amethyst
    Landego, Ivan
    Hajj, Carla
    Boardman, Alexander P.
    Dahi, Parastoo B.
    Ghosh, Arnab
    Giralt, Sergio
    Lin, Richard J.
    Park, Jae
    Scordo, Michael
    Salles, Gilles
    Yahalom, Joachim
    Palomba, Maria L.
    Schoeder, Heiko
    Perales, Miguel-Angel
    Shouval, Roni
    Imber, Brandon S.
    CLINICAL CANCER RESEARCH, 2024, 30 (22) : 5083 - 5093
  • [32] CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY IN ADULT PATIENTS WITH B-CELL LYMPHOPROLIFERATIVE DISEASES
    Gavrilina, O. A.
    Galstyan, G. M.
    Shchekina, A. E.
    Kotova, E. S.
    Maschan, M. A.
    Troitskaya, V. V.
    Koroleva, D. A.
    Zvonkov, E. E.
    Fidarova, Z. T.
    Vasilyeva, V. A.
    Parovichnikova, E. N.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2022, 67 (01): : 8 - 28
  • [33] The impact of bridging therapy prior to CD19-directed chimeric antigen receptor T-cell therapy in patients with large B-cell lymphoma
    Lutfi, Forat
    Holtzman, Noa G.
    Kansagra, Ankit J.
    Ali, Moaath Mustafa
    Bukhari, Ali
    Yan, Jingsheng
    Samanta, Santanu
    Gottlieb, David
    Kim, Dong W.
    Matsumoto, Lisa R.
    Gahres, Natalie
    Ruehle, Kathleen
    Lee, Seung T.
    Kocoglu, Mehmet H.
    Atanackovic, Djordje
    Yared, Jean A.
    Hardy, Nancy M.
    Molitoris, Jason
    Mohindra, Pranshu
    Rapoport, Aaron P.
    Dahiya, Saurabh
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 195 (03) : 405 - 412
  • [34] Salvage Treatment with Novel Agents Is Preferable to Standard Chemotherapy in Patients with Large B-Cell Lymphoma Progressing after Chimeric Antigen Receptor T-Cell Therapy
    Iacoboni, Gloria
    Iraola-Truchuelo, Josu
    Mussetti, Alberto
    Fernandez-Caldas, Paula
    Navarro Garces, Victor
    Martin Lopez, Ana Africa
    Delgado, Javier
    Perez Martinez, Ariadna
    Guerreiro, Manuel
    Carolina Caballero Gonzalez, Ana Carolina
    Martinez-Cibrian, Nuria
    Luzardo Henriquez, Hugo Daniel
    Sanchez, Jose M.
    Sancho, Juan-Manuel
    Barba, Pere
    Kwon, Mi
    Lopez Corral, Lucia
    Hernani, Rafael
    Luis Reguera, Juan
    Sureda, Anna
    Martin Garcia-Sancho, Alejandro
    Bastos-Oreiro, Mariana
    Abrisqueta, Pau
    BLOOD, 2022, 140
  • [35] Cost Effectiveness of Chimeric Antigen Receptor T-Cell Therapy in Multiply Relapsed or Refractory Adult Large B-Cell Lymphoma
    Lin, John K.
    Muffly, Lori S.
    Spinner, Michael A.
    Barnes, James, I
    Owens, Douglas K.
    Goldhaber-Fiebert, Jeremy D.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (24) : 2105 - +
  • [36] Health State Utilities for Adverse Events Associated with Chimeric Antigen Receptor T-Cell Therapy in Large B-Cell Lymphoma
    Howell, Timothy A.
    Matza, Louis S.
    Jun, Monika P.
    Garcia, Jacob
    Powers, Annette
    Maloney, David G.
    PHARMACOECONOMICS-OPEN, 2022, 6 (03) : 367 - 376
  • [37] Health State Utilities for Adverse Events Associated with Chimeric Antigen Receptor T-Cell Therapy in Large B-Cell Lymphoma
    Timothy A. Howell
    Louis S. Matza
    Monika P. Jun
    Jacob Garcia
    Annette Powers
    David G. Maloney
    PharmacoEconomics - Open, 2022, 6 : 367 - 376
  • [38] Bullous and Exanthematous Lesions Associated With Chimeric Antigen Receptor T-Cell Therapy in a Patient With Diffuse Large B-Cell Lymphoma
    Hu, Yongxian
    Zheng, Weiyan
    Qiao, Jianjun
    Cui, Qu
    Zhu, Yuanyuan
    Chang, Alex H.
    Huang, He
    JAMA DERMATOLOGY, 2020, 156 (09) : 1026 - 1028
  • [39] Outcomes of Chimeric Antigen Receptor (CAR) T-Cell Therapy in Patients with Large B-Cell Lymphoma (LBCL): A Single-Institution Experience
    Trando, Aaron
    Ter-Zakarian, Anna
    Yeung, Phillip
    Goodman, Aaron M.
    Hamdan, Ayad
    Hurley, Michael
    Jeong, Ah-Reum
    Tzachanis, Dimitrios
    CANCERS, 2023, 15 (18)
  • [40] Prognostic impact of peripheral eosinophil counts in patients with diffuse large B-cell lymphoma receiving chimeric antigen receptor T-cell therapy
    Dang, Xiuyong
    Ye, Shiguang
    Zhou, Lili
    Lu, Yan
    Li, Ping
    Liang, Aibin
    Qian, Wenbin
    CYTOTHERAPY, 2023, 25 (06) : 573 - 577
12345